Metformin and Multaq drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Metformin and Multaq. Common interactions include alopecia among females and gastrointestinal haemorrhage among males.
The phase IV clinical study analyzes what interactions people who take Metformin and Multaq have. It is created by eHealthMe based on reports of 452 people who take Metformin and Multaq from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
452 people who take Metformin and Multaq together, and have interactions are studied.
What is Metformin?
Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 405,808 Metformin users for its effectiveness, alternative drugs and more.
What is Multaq?
Multaq has active ingredients of dronedarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 10,504 Multaq users for its effectiveness, alternative drugs and more.
Number of Metformin and Multaq reports submitted per year:
Metformin and Multaq drug interactions by gender *:
Metformin and Multaq drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Metformin and Multaq?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- T.Audi Yanto, I.Huang, F.Nathania Kosasih, NP Hardjo Lugito, "Nightmare and Abnormal Dreams: Rare Side Effects of Metformin?", Case Reports in Endocrinology, 2018 Jan .
- Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
- Wiwanitkit S, Wiwanitkit V, "Metformin and sleep disorders", Indian journal of endocrinology and metabolism, 2012 Jan .
Alternative drugs to, pros and cons of the 2 drugs:
Common Metformin and Multaq interactions:
Browse all drug interactions of Metformin and Multaq:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Metformin interactions:
Browse all interactions between Metformin and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Multaq interactions:
Browse all interactions between Multaq and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on metformin hydrochloride and dronedarone hydrochloride (the active ingredients of Metformin and Multaq, respectively), and Metformin and Multaq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Metformin and Multaq.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rocephin and Magnesium drug interaction - 29 seconds ago
- Cytosar-U and Blood Alkaline Phosphatase Increased - 42 seconds ago
- Thyrogen and Fear - 50 seconds ago
- Botox Cosmetic and Eyelid Irritation - 58 seconds ago
- Retevmo and Appetite - Decreased - a minute ago
- Retevmo and Appetite Decreased - a minute ago
- Xeloda and Hypercalcaemia - a minute ago
- Letrozole and Facial Paresis - a minute ago
- Lipitor and Brain Surgery - a minute ago
- Slow-K and Tagrisso drug interaction - a minute ago